Free Trial

bioAffinity Technologies (BIAF) Short Interest Ratio & Short Volume

bioAffinity Technologies logo
$0.83 +0.02 (+2.47%)
Closing price 02/21/2025 03:49 PM Eastern
Extended Trading
$0.80 -0.03 (-4.22%)
As of 02/21/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

bioAffinity Technologies Short Interest Data

bioAffinity Technologies (BIAF) has a short interest of 396,800 shares, representing 4.21% of the float (the number of shares available for trading by the public). This marks a -7.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 72,980 shares to cover all short positions.

Current Short Interest
396,800 shares
Previous Short Interest
427,500 shares
Change Vs. Previous Month
-7.18%
Dollar Volume Sold Short
$301,568.00
Short Interest Ratio
2.3 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
15,590,000 shares
Float Size
9,420,000 shares
Short Percent of Float
4.21%
Today's Trading Volume
78,514 shares
Average Trading Volume
72,980 shares
Today's Volume Vs. Average
108%
Short Selling bioAffinity Technologies?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for bioAffinity Technologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BIAF Short Interest Over Time

BIAF Days to Cover Over Time

BIAF Percentage of Float Shorted Over Time

bioAffinity Technologies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2025396,800 shares $301,568.00 -7.2%4.2%2.3 $0.76
1/15/2025427,500 shares $320,625.00 +275.0%4.5%2.3 $0.75
12/31/2024114,000 shares $103,740.00 -35.8%1.2%0.8 $0.91
12/15/2024177,500 shares $165,075.00 +33.4%1.9%1.2 $0.93
11/30/2024133,100 shares $161,716.50 -41.2%1.4%1 $1.22
11/15/2024226,200 shares $296,322.00 -16.7%2.4%1.8 $1.31
10/31/2024271,400 shares $388,102.00 -39.4%3.7%2.4 $1.43
10/15/2024447,500 shares $886,050.00 +13.0%6.0%3.2 $1.98
9/30/2024396,200 shares $824,096.00 +18.0%5.3%3.6 $2.08
9/15/2024335,900 shares $584,466.00 +59.3%4.5%3 $1.74
8/31/2024210,900 shares $316,350.00 -27.8%2.8%2 $1.50
8/15/2024291,900 shares $504,987.00 -58.8%4.5%2.7 $1.73
7/31/2024708,000 shares $1.76 million +17.3%12.6%5.9 $2.49
7/15/2024603,700 shares $1.53 million +9.3%10.7%6 $2.53
6/30/2024552,600 shares $1.19 million -1.9%9.8%4.9 $2.16
6/15/2024563,400 shares $1.13 million +8.7%9.6%4.6 $2.00
5/31/2024518,400 shares $1.24 million +22.6%8.6%3.2 $2.40
5/15/2024423,000 shares $795,240.00 +7.1%7.1%1.7 $1.88
4/30/2024395,000 shares $967,750.00 +64.0%6.7%1.7 $2.45
4/15/2024240,900 shares $664,884.00 +337.2%4.4%1.1 $2.76
3/31/202455,100 shares $111,302.00 -12.1%1.3%0.3 $2.02
3/15/202462,700 shares $119,130.00 +148.8%1.8%0.4 $1.90
2/29/202425,200 shares $58,464.00 +159.8%0.7%0.2 $2.32
2/15/20249,700 shares $14,647.00 +73.2%0.3%0.4 $1.51
1/31/20245,600 shares $8,792.00 -60.6%0.2%0.4 $1.57
1/15/202414,200 shares $21,158.00 -47.6%0.4%1 $1.49
12/31/202327,100 shares $39,850.55 -45.3%0.7%2 $1.47
12/15/202349,500 shares $76,230.00 +32.4%1.3%3.5 $1.54
11/30/202337,400 shares $62,084.00 -17.8%1.0%3 $1.66
11/15/202345,500 shares $64,382.50 -2.2%1.2%5.6 $1.42
10/31/202346,500 shares $58,664.40 -7.7%1.3%6 $1.26
10/15/202350,400 shares $66,900.96 +39.6%1.4%5.7 $1.33
9/30/202336,100 shares $42,013.18 -43.9%1.1%3.3 $1.16
9/15/202364,300 shares $108,667.00 +7.4%1.7%5.8 $1.69
8/31/202359,900 shares $103,627.00 -9.5%1.7%5.1 $1.73
8/15/202366,200 shares $122,801.00 -5.2%1.8%4.7 $1.86
7/31/202369,800 shares $122,848.00 -7.4%1.9%4.7 $1.76
7/15/202375,400 shares $133,458.00 -10.2%2.1%4.5 $1.77
6/30/202384,000 shares $153,720.00 +7.4%2.3%4.5 $1.83
6/15/202378,200 shares $139,978.00 +22.8%2.1%3.6 $1.79
Nvidia’s Next Big Move Comes on Feb. 26 (Ad)

Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of companies partnering with Nvidia on its latest AI Superproject … Companies we refer to as Nvidia's "Silent Partners" … And they could benefit greatly as well on Feb. 26.

Click here to find out who they are.
5/31/202363,700 shares $116,571.00 -0.6%1.7%2.9 $1.83
5/15/202364,100 shares $116,662.00 No Change1.2%1.9 $1.82

BIAF Short Interest - Frequently Asked Questions

What is bioAffinity Technologies' current short interest?

Short interest is the volume of bioAffinity Technologies shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 396,800 shares of BIAF short. 4.21% of bioAffinity Technologies' shares are currently sold short. Learn More on bioAffinity Technologies' current short interest.

What is a good short interest ratio for bioAffinity Technologies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIAF shares currently have a short interest ratio of 2.0. Learn More on bioAffinity Technologies's short interest ratio.

What is a good short interest percentage for bioAffinity Technologies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.21% of bioAffinity Technologies' floating shares are currently sold short.

Is bioAffinity Technologies' short interest increasing or decreasing?

bioAffinity Technologies saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 396,800 shares, a decline of 7.2% from the previous total of 427,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is bioAffinity Technologies' float size?

bioAffinity Technologies currently has issued a total of 15,590,000 shares. Some of bioAffinity Technologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. bioAffinity Technologies currently has a public float of 9,420,000 shares.

How does bioAffinity Technologies' short interest compare to its competitors?

4.21% of bioAffinity Technologies' shares are currently sold short. Here is how the short interest of companies in the industry of "business services" compare to bioAffinity Technologies: Fluent, Inc. (0.31%), SPAR Group, Inc. (1.04%), IZEA Worldwide, Inc. (0.25%), ShiftPixy, Inc. (71.76%), Katapult Holdings, Inc. (5.08%), Scienjoy Holding Co. (0.01%), MoneyHero Limited (0.67%), comScore, Inc. (1.29%), BIT Mining Limited (0.91%), Swvl Holdings Corp. (1.71%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short bioAffinity Technologies stock?

Short selling BIAF is an investing strategy that aims to generate trading profit from bioAffinity Technologies as its price is falling. BIAF shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against bioAffinity Technologies?

A short squeeze for bioAffinity Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIAF, which in turn drives the price of the stock up even further.

How often is bioAffinity Technologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIAF, twice per month. The most recent reporting period available is January, 31 2025.




This page (NASDAQ:BIAF) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners